Calpain-10 gene polymorphism is associated with reduced β3-adrenoceptor function in human fat cells

被引:38
作者
Hoffstedt, J
Näslund, E
Arner, P
机构
[1] Huddinge Univ Hosp, Dept Med, SE-14186 Stockholm, Sweden
[2] Danderyd Hosp, Karolinska Inst, Dept Surg, SE-14186 Stockholm, Sweden
关键词
D O I
10.1210/jc.87.7.3362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polymorphism in the calpain-10 gene is linked to type 2 diabetes, insulin resistance, and decreased thermogenesis. In view of the role of beta-adrenoceptors in thermogenesis we investigated the relationship between beta(1)-, beta(2)-, and beta(3)-adrenoceptor-stimulated lipolysis in abdominal sc fat cells and 3 different previously described single nucleotide polymorphisms (SNPs) in the calpain-10 gene (SNP-19, SNP-43, and SNP-63). The study sample comprised 240 healthy subjects. A strong association between lipolytic beta(3)-receptor function in adipocytes and the SNP-19, which is a deletion/insertion (1/2) was observed in overweight subjects (body mass index, >25 kg/m(2)), but not in lean ones. No association was found between any of the polymorphisms and lipolytic function of either beta(1)- or beta(2)-receptors. Carriers of 1/1 in SNP-19 had 30-fold decreased lipolytic sensitivity of beta(3)-adrenoceptors in comparison to 1/2 or 212 carriers (P = 0.0019, by ANOVA). This was found in both genders and was not influenced by SNP-43 or SNP-63 in the calpain-10 gene or by the Trp(64)Arg polymorphism in the beta(3)-adrenoceptor gene. In conclusion, a deletion/insertion polymorphism in the calpain-10 gene (SNP-19) is associated with reduced beta(3)-adrenoceptor function in obesity. This could be of importance for regulating thermogenesis in overweight subjects.
引用
收藏
页码:3362 / 3367
页数:6
相关论文
共 26 条
[11]  
Hoffstedt J, 1996, INT J OBESITY, V20, P428
[12]   Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus [J].
Horikawa, Y ;
Oda, N ;
Cox, NJ ;
Li, XQ ;
Orho-Melander, M ;
Hara, M ;
Hinokio, Y ;
Lindner, TH ;
Mashima, H ;
Schwarz, PEH ;
del Bosque-Plata, L ;
Horikawa, Y ;
Oda, Y ;
Yoshiuchi, I ;
Colilla, S ;
Polonsky, KS ;
Wei, S ;
Concannon, P ;
Iwasaki, N ;
Schulze, T ;
Baier, LJ ;
Bogardus, C ;
Groop, L ;
Boerwinkle, E ;
Hanis, CL ;
Bell, GI .
NATURE GENETICS, 2000, 26 (02) :163-175
[13]   Modulation of human cardiac function through 4 beta-adrenoceptor populations [J].
Kaumann, AJ ;
Molenaar, P .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (06) :667-681
[14]   DRUGS AND RECEPTORS - AN OVERVIEW OF THE CURRENT STATE OF KNOWLEDGE [J].
KENAKIN, T .
DRUGS, 1990, 40 (05) :666-687
[15]  
KOLACZYNSKI JW, 1994, INT J OBESITY, V18, P161
[16]  
Konkar AA, 2000, MOL PHARMACOL, V57, P252
[17]  
LONNQVIST F, 1993, BRIT J PHARMACOL, V110, P929
[18]   Characterization and expression of calpain 10 - A novel ubiquitous calpain with nuclear localization [J].
Ma, H ;
Fukiage, C ;
Kim, YH ;
Duncan, MK ;
Reed, NA ;
Shih, M ;
Azuma, M ;
Shearer, TR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :28525-28531
[19]   Subcutaneous adipose tissue metabolism at menopause:: Importance of body fatness and regional fat distribution [J].
Mauriège, P ;
Imbeault, P ;
Prud'Homme, D ;
Tremblay, A ;
Nadeau, A ;
Després, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2446-2454
[20]   New insights into sympathetic regulation of glucose and fat metabolism [J].
Nonogaki, K .
DIABETOLOGIA, 2000, 43 (05) :533-549